Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Current Assets (2018 - 2025)

Avai Bio's Current Assets history spans 7 years, with the latest figure at $116082.0 for Q1 2024.

  • On a quarterly basis, Current Assets rose 7.91% to $116082.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $116082.0, a 7.91% increase, with the full-year FY2024 number at $116082.0, up 7.91% from a year prior.
  • Current Assets hit $116082.0 in Q1 2024 for Avai Bio, up from $38047.0 in the prior quarter.
  • Over the last five years, Current Assets for AVAI hit a ceiling of $620293.0 in Q3 2020 and a floor of $635.0 in Q2 2023.
  • Historically, Current Assets has averaged $228864.6 across 5 years, with a median of $172737.0 in 2020.
  • Biggest five-year swings in Current Assets: soared 103776.99% in 2020 and later plummeted 99.74% in 2023.
  • Tracing AVAI's Current Assets over 5 years: stood at $384321.0 in 2020, then skyrocketed by 61.4% to $620293.0 in 2021, then plummeted by 76.27% to $147180.0 in 2022, then crashed by 74.15% to $38047.0 in 2023, then skyrocketed by 205.1% to $116082.0 in 2024.
  • Business Quant data shows Current Assets for AVAI at $116082.0 in Q1 2024, $38047.0 in Q4 2023, and $1594.0 in Q3 2023.